At the IGTP TODAY
On 21 March, the final meeting of INNOVA4TB, a consortium led by IGTP with researchers from around the world, took place. Participants presented the results of the different work packages and evaluated the work done since 2019. IGTP will continue to be involved in other networks such as ADVANCE-TB and SMA-TB.
To commemorate International Women's Day, we asked four questions to researchers from various profiles at IGTP and professionals from different research support areas. The aim is to understand the difficulties they have faced as women in their professional field and to gain insight into their perspectives on the future.
On 7 February, "#100tífiques" returned for its sixth edition, a macro-event that has become a benchmark for advocacy within the Catalan female research community and schools. Expanding on last year's participant numbers, thirteen scientists from IGTP took part in this event.
An international trial has investigated the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19. The results show that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for. Nearly 4,000 healthcare workers took part in the BRACE trial across 36 sites from five countries, including the Germans Trias Hospital. Researchers from an IGTP tuberculosis research group were involved in the development of the study, which has been published in the New England Journal of Medicine.
A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibiotic sensitivity or resistance and its clinical implications. The consensus document provides guidance for the design of therapeutic regimens and the optimization of treatments, and is intended to help clinicians manage tuberculosis patients. The paper, published in The Lancet Infectious Diseases and led by Dr José Domínguez from IGTP, is an update of a similar statement made in 2016.
_1678377436.JPG)
In the first episode, "La tuberculosi: la pandèmia dels pobres" (Tuberculosis: the pandemic of the poor), researcher José Domínguez explains the basics of the disease and the current situation of research. This podcast is a way for the centre to reach a wide audience, thanks to a short and dynamic storytelling format.
The COST Programme (European Cooperation in Science and Technology) has approved 70 new actions and Spain is coordinating nine of them, making it second in the ranking of countries leading COST Actions after Italy, which is coordinating ten. Three of the Spanish projects are from the Germans Trias i Pujol Research Institute (IGTP) and two of these are being led by the IGTP. COST Actions run for four years and this round will start in the coming autumn.
The Germans Trias i Pujol Research Institute (IGTP) has participated in a ground-breaking event to bring art and science together for European Performing Science Night with results that left nobody indifferent. The Fundació Èpica la Fura dels Baus led the project which involved artists and scientists from the IGTP and four international universities.
Next weekend Badalona will be the site of European Performance Science Night 2021, an activity within the framework of the European Researchers' Night, financed by the Marie Sklodowska-Curie Actions (MSCA). The Germans Trias i Pujol Research Institute (IGTP) has joined forces with one of the projects within this initiative led by the Épica Foundation La Fura dels Baus (a world-famous Catalan theatre company), with the aim of bringing science to the citizen and motivating young people to take up scientific careers
A total of 23 researchers have taken part in the first event of the European project European Performing Science Night (EPSN) part of European Researcher's Night a European public event that brings scientists and society together. All three research groups on the camps taking part in the project participated in the workshop.
